In addition to PHLPP2, one of the protein-protein interactions identified in the mass spectrometry experiment was EIF3A (one of the RNA-binding components) that is required for the initiation of protein synthesis, and its expression was associated with the response of lung cancer patients to platinum-based chemotherapy through the regulation of DNA repair pathways [38]. The gene discussed is EIF3A; the disease is lung carcinoma.